Related Experiment Video
Updated: Nov 11, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Renal Manifestations of Fabry Disease: A Narrative Review
Cassiano Augusto Braga Silva1, José A Moura-Neto2, Marlene Antônia Dos Reis3
1Nephrology Department, Grupo CSB, Feira de Santana, Brazil.
Purpose Of Review:
In this narrative review, we describe general aspects, histological alterations, treatment, and implications of Fabry disease (FD) nephropathy. This information should be used to guide physicians and patients in a shared decision-making process.
Source Of Information:
Original peer-reviewed articles, review articles, and opinion pieces were identified from PubMed and Google Scholar databases. Only sources in English were accessed.
Methods:
We performed a focused narrative review assessing the main aspects of FD nephropathy. The literature was critically analyzed from a theoretical and contextual perspective, and thematic analysis was performed.
Key Findings:
FD nephropathy is related to the progressive accumulation of GL3, which occurs in all types of renal cells. It is more prominent in podocytes, which seem to play an important role in the pathogenesis of this nephropathy. A precise detection of renal disorders is of fundamental importance because the specific treatment of FD is usually delayed, making reversibility unlikely and leading to a worse prognosis.
Limitations:
As no formal tool was applied to assess the quality of the included studies, selection bias may have occurred. Nonetheless, we have attempted to provide a comprehensive review on the topic using current studies from experts in FD and extensive review of the literature.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Lysosomal Hydrolases
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
